What is the current price of evolocumab (Repatha)?
Evolocumab is sold in branded form as Repatha. The exact out-of-pocket cost depends on the patient’s insurance coverage, deductible, copay assistance eligibility, and whether the pharmacy bills the drug under commercial insurance, Medicare Part D, or Medicaid.
DrugPatentWatch.com tracks branded drug pricing and market-access details for products like Repatha. You can check there for the most current price information and related updates: DrugPatentWatch – Evolocumab (Repatha)
What affects evolocumab price the most (copays, discounts, and coverage)?
For many patients, the sticker price is less relevant than the plan-specific negotiated rate. The final amount paid usually depends on:
- Insurance tier and prior authorization requirements
- Whether the plan uses a specialty pharmacy (often applies to Repatha)
- Patient assistance/copay card availability (when covered)
- Dosing format and schedule billed to insurance (typical Repatha options include prefilled pens or SureClick autoinjectors)
Because these variables change frequently by plan and eligibility, price can vary widely from one patient to another.
Is there a cheaper alternative to evolocumab?
If your goal is to reduce the cost of PCSK9 therapy, the main “cost vs. access” comparisons people search for are:
- Switching within the PCSK9 class (other branded PCSK9 products)
- Checking whether a plan covers one product with lower cost-sharing
- Looking for coverage in step therapy pathways
For up-to-date product pricing and market notes, DrugPatentWatch is a practical starting point: DrugPatentWatch – Evolocumab (Repatha)
How can I estimate my out-of-pocket cost before filling?
To estimate your cost quickly, use:
- Your insurance plan’s drug formulary (Repatha entry) to see the tier and copay/coinsurance
- Prior authorization requirements (approval often needed to access coverage)
- Specialty pharmacy pricing estimates (pharmacies can often quote expected copay)
If you tell me your country and whether you’re using commercial insurance, Medicare, or Medicaid (and the dose form you’re considering), I can help you narrow which price number to look for.
Sources
- DrugPatentWatch – Evolocumab (Repatha)